Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole vs Esomeprazole for GERD
NCT02860624Phase 3Completed
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Dec 2011
- Primary completion
- Apr 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ilaprazole in gastroesophageal reflux disease (GERD), erosive esophagitis (EE), sponsored by Livzon Pharmaceutical Group Inc.. Started Dec 2011; status: completed.
02
Drugs
ilaprazole
03
Conditions
gastroesophageal reflux disease (GERD)erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT02860624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02860624.